>10 Percent of FIT Are Unsatisfactory and Cannot Be Processed
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 22, 2023 -- More than 10 percent of fecal immunochemical tests (FIT) for colorectal cancer cannot be processed by a laboratory, and fewer than half complete a subsequent FIT within 15 months, according to a study published online Nov. 3 in Cancer Epidemiology, Biomarkers & Prevention.
Po-Hong Liu, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues conducted a retrospective cohort study to examine unsatisfactory FIT among average-risk individuals aged 50 to 74 years who completed an index FIT from 2010 to 2019. Factors associated with unsatisfactory FIT and subsequent testing were examined.
Overall, 10.2 percent of 56,980 individuals completing an index FIT had an unsatisfactory FIT. The researchers found that reasons for unsatisfactory FIT included inadequate specimen, incomplete labeling, old specimen, and broken/leaking container (51, 27, 13, and 8 percent, respectively). The odds of unsatisfactory FIT were increased in association with being male, Black, Spanish speaking, on Medicaid, and receiving FIT by mail (odds ratios, 1.10, 1.46, 1.12, 1.42, and 2.66, respectively). Fewer than half of those with an unsatisfactory FIT completed a subsequent test within 15 months (41 percent at a median of 4.4 months). The likelihood of completing a subsequent test was increased for adults aged 50 to 54 years and those who received FIT by mail (odds ratios, 1.16 and 1.92, respectively).
"Our results may inform design of patient education and system improvement strategies to improve screening delivery in real-world settings," the authors write.
Two authors disclosed ties to Freenome.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Sociodemographics Tied to Rehab Use During Critical Illness Hospitalization
FRIDAY, May 10, 2024 -- For older adults hospitalized with a stay in the intensive care unit (ICU), social determinants of health (SDOH) are associated with use of skilled...
Breakthrough Gene Therapy Enables Infant Born Deaf to Hear
FRIDAY, May 10, 2024 -- Significant hearing improvements have been achieved in an infant with profound hearing loss due to a biallelic otoferlin gene (OTOF) mutation, according to...
Implantable Continuous Flow Device Feasible for Small Children With Severe Systolic Heart Failure
FRIDAY, May 10, 2024 -- The Jarvik 2015 left ventricular assist device (LVAD) seems promising as an implantable continuous flow device for small children with severe systolic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.